AbClon Inc Asset Resilience Ratio

Latest as of June 2026: 9.30%

AbClon Inc asset resilience ratio. AbClon Inc (174900) has an Asset Resilience Ratio of 9.30% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 174900 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩6.00 Billion

≈ $4.07 Million USD Cash + Short-term Investments

Total Assets

₩64.50 Billion

≈ $43.71 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of AbClon Inc (2015–2025)

Asset resilience ratio of AbClon Inc from 2015 to 2025. This chart shows how AbClon Inc's Asset Resilience Ratio has changed over time. Read 174900 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down AbClon Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 174900 total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩6.00 Billion	9.3%
Total Liquid Assets	₩6.00 Billion	9.30%

Asset Resilience Insights

Limited Liquidity: AbClon Inc maintains only 9.30% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

AbClon Inc Industry Peers by Asset Resilience Ratio

Compare AbClon Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

AbClon Inc Asset Resilience Ratio by Year (2015–2025)

AbClon Inc asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for AbClon Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	8.48%	₩6.00 Billion ≈ $4.07 Million	₩70.75 Billion ≈ $47.94 Million	-36.89pp
2024-12-31	45.37%	₩21.86 Billion ≈ $14.82 Million	₩48.18 Billion ≈ $32.65 Million	+6.85pp
2023-12-31	38.53%	₩17.50 Billion ≈ $11.86 Million	₩45.42 Billion ≈ $30.78 Million	-6.13pp
2022-12-31	44.65%	₩24.14 Billion ≈ $16.36 Million	₩54.06 Billion ≈ $36.64 Million	+10.24pp
2021-12-31	34.42%	₩10.27 Billion ≈ $6.96 Million	₩29.83 Billion ≈ $20.21 Million	-14.30pp
2020-12-31	48.72%	₩19.55 Billion ≈ $13.25 Million	₩40.13 Billion ≈ $27.20 Million	-11.83pp
2019-12-31	60.55%	₩28.44 Billion ≈ $19.27 Million	₩46.97 Billion ≈ $31.83 Million	-11.02pp
2018-12-31	71.57%	₩20.54 Billion ≈ $13.92 Million	₩28.70 Billion ≈ $19.45 Million	-10.40pp
2017-12-31	81.97%	₩17.10 Billion ≈ $11.59 Million	₩20.87 Billion ≈ $14.14 Million	+9.25pp
2016-12-31	72.72%	₩11.64 Billion ≈ $7.89 Million	₩16.01 Billion ≈ $10.85 Million	+10.87pp
2015-12-31	61.85%	₩10.00 Billion ≈ $6.78 Million	₩16.17 Billion ≈ $10.96 Million	--

pp = percentage points

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$240.63 Million

₩355.07 Billion KRW

Market Cap Rank

#15640 Global

#535 in Korea

Share Price

₩17820.00

Change (1 day)

+3.30%

52-Week Range

₩16820.00 - ₩89100.00

All Time High

₩90600.00